Our powerful patented genomics solutions and unique approaches aid early cancer detection, help tailor therapy, and boost the drug discovery processes. Our proprietary approaches based on novel biology insights have led to incredibly innovative solutions in several cancers and difficult-to-treat situations. Our reliance on carefully defined clinical phenotypes to parse genomic data has helped clear the clutter and has resulted in phenomenal clarity and discovery of new mechanisms that are causal in disease presentation and behavior. This approach has also led to true personalization of diagnosis and care planning.

Our solutions are tailored by cancer type, treatment, and ethnicity, perhaps the only company in the world to do so.

We work with pharmaceutical companies to provide proprietary omics solutions in their clinical trials of novel molecules/ novel indications, that make their path less chance-prone, less expensive, and much faster, thus saving them cost, time, and conserving valuable patent life.

We detect early, treat right every patient, every time.

Many of our solutions are oncologist-driven – we work closely with oncologists to define unmet clinical needs and then convert the needs raised by oncologists to collaborative R&D programs that yield unique solutions which are then adopted by oncologists in improving diagnosis and care. We aim to provide the most personalization to patients.

Utilizing state-of-the-art technology, along with profound clinical and biological insights, we leverage our proprietary bioinformatic analysis and interpretation platforms to deliver cutting-edge science for clinical decision-making.

Partners

Trucan partnership programs enable focused genomics research studies that yield translatable results in oncology decision-making and care. We partner with leading academics, physicians, and biotechnology companies in selecting problems to solve and developing solutions with them. We aim to develop solutions that will be eminently implementable at the bedside and practice-changing. These collaborations also lead to novel insights into disease biology and novel approaches to diagnosis/detection and treatment. We focus on precision translational medicine in order to find and validate novel targets and develop unique diagnostics including companion diagnostics, which are all intended to improve quality of life and increase disease-free survival.

Contact us at partnering@trucansentinel.com regarding business and academic collaborations.

Patents

Our company is taking a global approach to protecting our intellectual property by filing patents worldwide. We understand the importance of safeguarding our inventions and technologies in different countries to ensure our competitive edge in the international market.